Drug Firm Cipla today said it will raise Rs 676 crore through the issue of equity shares on institutional placement basis.
The board of directors of the company have approved the issuance of up to 2.56 crore equity shares at Rs 263.75 per equity share, thus garnering Rs 676 crore, Cipla said in a filing to the Bombay Stock Exchange (BSE).
The QIP issue closed on Thursday.
Shares of the company were trading at Rs 261.50, up 0.97 per cent on the BSE.
The filing further said the price of the QIP issue was fixed at Rs 263.75 per share.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app